Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun;14(2):452-470.
doi: 10.1007/s12539-021-00499-4. Epub 2022 Feb 8.

Clinical and Laboratory Approach to Diagnose COVID-19 Using Machine Learning

Affiliations

Clinical and Laboratory Approach to Diagnose COVID-19 Using Machine Learning

Krishnaraj Chadaga et al. Interdiscip Sci. 2022 Jun.

Abstract

Coronavirus 2 (SARS-CoV-2), often known by the name COVID-19, is a type of acute respiratory syndrome that has had a significant influence on both economy and health infrastructure worldwide. This novel virus is diagnosed utilising a conventional method known as the RT-PCR (Reverse Transcription Polymerase Chain Reaction) test. This approach, however, produces a lot of false-negative and erroneous outcomes. According to recent studies, COVID-19 can also be diagnosed using X-rays, CT scans, blood tests and cough sounds. In this article, we use blood tests and machine learning to predict the diagnosis of this deadly virus. We also present an extensive review of various existing machine-learning applications that diagnose COVID-19 from clinical and laboratory markers. Four different classifiers along with a technique called Synthetic Minority Oversampling Technique (SMOTE) were used for classification. Shapley Additive Explanations (SHAP) method was utilized to calculate the gravity of each feature and it was found that eosinophils, monocytes, leukocytes and platelets were the most critical blood parameters that distinguished COVID-19 infection for our dataset. These classifiers can be utilized in conjunction with RT-PCR tests to improve sensitivity and in emergency situations such as a pandemic outbreak that might happen due to new strains of the virus. The positive results indicate the prospective use of an automated framework that could help clinicians and medical personnel diagnose and screen patients.

Keywords: Artificial Intelligence; Blood tests; COVID-19; Machine Learning; RT-PCR.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interest.

Figures

Fig. 1
Fig. 1
Integral learning steps required for the development of ML classifiers
Fig. 2
Fig. 2
Null values present in attributes
Fig. 3
Fig. 3
Pearson co-relation matrix
Fig. 4
Fig. 4
An example of synthetic sampling by SMOTE overall flow diagram is given below [34]
Fig. 5
Fig. 5
Block diagram describing the proposed method for the classification of COVID-19 based on blood sample data
Fig. 6
Fig. 6
AUROC curves of the various ML algorithms as follows: a Initial RF model; b RF model after pre-processing; c RF model after hyperparameter tuning; d Model after SMOTE Analysis; e Optimized RF model; f Logistic Regression; g KNN; h XGBoost
Fig. 7
Fig. 7
Feature importance using SHAP
Fig. 8
Fig. 8
Feature importance using random forest
Fig. 9
Fig. 9
Marginal effect of Leukocytes, Monocytes and Platelets on COVID-19 outcome

Similar articles

Cited by

References

    1. WHO (2021) Coronavirus disease (covid-19). https://www.who.int/emergencies/diseases/novel-coronavirus-2019. Accessed 18 Dec 2021
    1. Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, Bleicker T, Brünink S, Schneider J, Schmidt ML, Mulders DG. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Eurosurveillance. 2020;25:2000045. doi: 10.2807/1560-7917.es.2020.25.3.2000045. - DOI
    1. Döhla M, Boesecke C, Schulte B, Diegmann C, Sib E, Richter E, Eschbach-Bludau M, Aldabbagh S, Marx B, Eis-Hübinger AM, Schmithausen RM. Rapid point-of-care testing for SARS-CoV-2 in a community screening setting shows low sensitivity. Public Health. 2020;180:170–172. doi: 10.1016/j.puhe.2020.04.009. - DOI
    1. Burog AI, Yacapin CP, Maglente RR, Macalalad-Josue AA, Uy EJ, Dans AL, Dans LF. Should IgM/IgG rapid test kit be used in the diagnosis of COVID-19. Asia Pac Center Evid Based Healthc. 2020;4:1–12. doi: 10.47895/amp.v54i0.1558. - DOI
    1. Browning L, Colling R, Rakha E, Rajpoot N, Rittscher J, James JA, Salto-Tellez M, Snead DR, Verrill C. Digital pathology and artificial intelligence will be key to supporting clinical and academic cellular pathology through COVID-19 and future crises: the PathLAKE consortium perspective. J Clin Pathol. 2021;74(7):443–447. doi: 10.1136/jclinpath-2020-206854. - DOI - PMC - PubMed